Biotech and Pharma

5 Issues to Watch within the Inflation Discount Act of 20225 Issues to Watch within the Inflation Discount Act of 2022

5 Issues to Watch within the Inflation Discount Act of 2022

[ad_1] Textual content measurement Democrat and Senate Majority Chief Chuck Schumer. Drew Angerer/Getty Photos Senate Democrats are getting nearer to…

3 years ago
A Recession Is Coming. These Are the Shares to Hunker Down In.A Recession Is Coming. These Are the Shares to Hunker Down In.

A Recession Is Coming. These Are the Shares to Hunker Down In.

[ad_1] Eli Salzmann loves nothing higher than discovering an organization that’s a “canine of a inventory with no momentum” however…

3 years ago
A Recession Is Coming. These Are the Shares to Hunker Down In.A Recession Is Coming. These Are the Shares to Hunker Down In.

A Recession Is Coming. These Are the Shares to Hunker Down In.

[ad_1] Eli Salzmann loves nothing higher than discovering an organization that’s a “canine of a inventory with no momentum” however…

3 years ago
Moderna’s Earnings Are Coming. This is What to Count on.Moderna’s Earnings Are Coming. This is What to Count on.

Moderna’s Earnings Are Coming. This is What to Count on.

[ad_1] Textual content dimension Moderna is growing two Covid-19 vaccines for the autumn. Joseph Prezioso / AFP by way of…

3 years ago
U.S. Stocks Poised for Lower Open on MondayU.S. Stocks Poised for Lower Open on Monday

U.S. Stocks Poised for Lower Open on Monday

[ad_1] Wall Street is poised to open lower on Monday ahead of a big week of economic data releases and…

3 years ago
Here’s What’s Stopping Stocks From Sinking Into a Bear Market After Friday’s FlirtHere’s What’s Stopping Stocks From Sinking Into a Bear Market After Friday’s Flirt

Here’s What’s Stopping Stocks From Sinking Into a Bear Market After Friday’s Flirt

[ad_1] The S&P 500 dipped a toe into bear market territory on Friday before pulling back to close higher than…

3 years ago
Antares Pharma Stock Soars After $960 Million Halozyme BuyoutAntares Pharma Stock Soars After $960 Million Halozyme Buyout

Antares Pharma Stock Soars After $960 Million Halozyme Buyout

[ad_1] Text size Nasdaq-listed Antares Pharma is being bought by Halozyme Therapeutics in a deal valued at $960 million. Michael…

3 years ago
The 8 Stocks in the S&P 500 That Are Still Negative Since the Pandemic LowsThe 8 Stocks in the S&P 500 That Are Still Negative Since the Pandemic Lows

The 8 Stocks in the S&P 500 That Are Still Negative Since the Pandemic Lows

[ad_1] Text size Chris Delmas/AFP via Getty Images Intel stock on Friday capped off its best week in more than…

3 years ago